Combining chemotherapy and BRAF oncogene inhibitors is a very effective strategy for fighting metastatic melanoma, the leading cause of death from skin cancer in the world.
Read morePivotal announced today that it has been contracted by Checkpoint Therapeutics Inc., a New York City-based biotechnology company, to provide expert clinical research services in Europe for its upco...
Read moreAt the end of the month of December 2019, we talked about the effectiveness of trichina as an adjuvant of cisplatin in treatment. Squamous cell carcinoma is the second most common type of skin canc...
Read moreThe UdL participates in an international investigation published in "Cell"
Read moreSquamous cell carcinomas are the second most frequent skin tumors. A high percentage of these tumors are treated by surgical excision. However, some advanced carcinomas are recurrent and show an aggre...
Read moreEl trabajo del CNIO contribuye a desvelar el proceso descubriendo "uno de los eslabones clave", un nuevo mecanismo que regula la diferenciación -evolución- de las células que integran la mayor part...
Read moreLos resultados han sido sorprendentes, ya que los animales desarrollaron cáncer de piel cinco meses antes de lo esperado
Read moreEl carcinoma de células escamosas, uno de los cánceres de piel más comunes, representa un 5% de todos los nuevos casos de cáncer registrados en las poblaciones de tipo caucásico.
Read moreEl Centro de Desarrollo de Sensores, Instrumentación y Sistemas (CD6), de la UPC en el Campus de Terrassa, lidera el proyecto de investigación europeo Diagnoptics, que tiene como finalidad desarroll...
Read more